Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huzhang Granules for Acute Gouty Arthritis
NCT04462666Phase 2Unknown
- Sponsor
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
- Start
- Jul 2020
- Primary completion
- Jul 2023
- Modality
- Botanical Extract
01
Overview
Phase 2, randomised, double-blind trial of polygonum cuspidatum in gouty arthritis, sponsored by Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Primary endpoint: Visual Analogue Scale at 5 days. Status: unknown.
02
Drugs
polygonum cuspidatum
03
Conditions
gouty arthritis
Beyond the preview
Go deeper on NCT04462666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04462666.